Marketing-authorisation holder
Serb Sa
8 medicines in 1 country, as authorisation holder and marketer.
Loading…
Marketing-authorisation holder
8 medicines in 1 country, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMVERSIO 1 G POLVO ORAL EFG1 g · Polvo oral | Betaine | Spain | Marketed | 2024 |
| CYANOKIT 2,5 g POLVO PARA SOLUCION PARA PERFUSION2,5 g · Polvo para solución para perfusión | Hydroxocobalamin | Spain | Authorised | 2008 |
| CYANOKIT 5 g POLVO PARA SOLUCION PARA PERFUSION5 g · Polvo para solución para perfusión | Hydroxocobalamin | Spain | Marketed | 2010 |
| FIRDAPSE 10 MG COMPRIMIDOS10 mg · Comprimido | Amifampridine | Spain | Authorised | 2015 |
| FLUORESCEINA OCULOS 10% SOLUCION INYECTABLE500 mg · Solución inyectable | Fluorescein | Spain | Marketed | 2003 |
| MYSOLINE 250 MG COMPRIMIDOS250 mg · Comprimido | Primidone | Spain | Marketed | 1953 |
| VORAXAZE 1.000 UNIDADES POLVO PARA SOLUCION INYECTABLE1000 UI/ml · Polvo para solución inyectable | Glucarpidase | Spain | Marketed | 2022 |
| XERMELO 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA327,9 mg · Comprimido recubierto con película | Telotristat etiprate | Spain | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 8 | 8 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Keep Serb Sa’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.